Compounds of formula (I)
##STR00001##
wherein R.sup.1, R.sup.2, R.sup.3, m, and Y are defined in the
specification are TRPA1 antagonists. Compositions comprising such
compounds and methods for treating conditions and disorders using such
compounds and compositions are also disclosed.